Evidence map›Paper›PMID 25512859›Full record

ReviewJournal of therapeutic ultrasound2013

The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus.

Jean-Francois Aubry, Kim Butts Pauly, Chrit Moonen, Gail Ter Haar, Mario Ries, Rares Salomir, Sham Sokka, Kevin Michael Sekins, Yerucham Shapira, Fangwei Ye and 11 more

Abstract readReview
In one paragraph

Review in Journal of therapeutic ultrasound, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review of Robot-Assisted HIFU Therapy.Sensors (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Breath-hold MR-HIFU hyperthermia: phantom andInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2019
    Article
  18. Article
  19. Article
  20. Equivalence of cell survival data for radiation dose and thermal dose in ablative treatments: analysis applied to essential tremor thalamotomy by focused ultrasound and gamma knife.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jean-Francois AubryInstitut Langevin, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Université Denis Diderot, Paris VII, Paris, France ; Department of Radiation Oncology, University of Virginia, Charlottesville, VA, USA.
Kim Butts PaulyRadiological Sciences Laboratory, Stanford University School of Medicine, Palo Alto, CA, USA.
Chrit MoonenImaging Division, University Medical Center Utrecht, Amsterdam, The Netherlands.
Gail Ter HaarDivision of Radiotherapy and Imaging, The Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK.
Mario RiesImaging Division, University Medical Center Utrecht, Amsterdam, The Netherlands.
Rares SalomirFaculty of Medicine, University of Geneva, Geneva, Switzerland.
Sham SokkaPhilips Healthcare, Boston, MA, USA.
Kevin Michael SekinsUltrasound Innovations Applications, Siemens Healthcare, Issaquah, WA, USA.
Yerucham ShapiraInSightec Ltd, 5 Nahum Heth Street, Haifa, Israel.
Fangwei YeChongqing Haifu Medical Technology Co., Ltd, Chongqing, China.
Heather Huff-SimoninFocused Ultrasound Foundation, Charlottesville, VA, USA.
Matt EamesFocused Ultrasound Foundation, Charlottesville, VA, USA.
Arik HananelFocused Ultrasound Foundation, Charlottesville, VA, USA.
Neal KassellFocused Ultrasound Foundation, Charlottesville, VA, USA.
Alessandro NapoliUniversity of Rome, La Sapienza, Rome, Italy.
Joo Ha HwangDigestive Disease Center, University of Washington, Seattle, WA, USA.
Feng WuInstitute of Ultrasonic Engineering in Medicine, Chongqing Medical University, Chongqing, China.
Lian ZhangClinical Center for Tumor Therapy, Second Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing, China.
Andreas MelzerInstitute for Medical Science and Technology, University of Dundee, Dundee, Scotland, UK.
Young-Sun KimDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Wladyslaw M GedroycDepartment of Medicine, Imperial College, South Kensington Campus, Exhibition Rd, London SW7 2AZ, UK ; Saint Mary's Hospital, Praed St, W2 1NY, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical use of high-intensity focused ultrasound (HIFU) under ultrasound or MR guidance as a non-invasive method for treating tumors is rapidly increasing. Tens of thousands of patients have been treated for uterine fibroid, benign prostate hyperplasia, bone metastases, or prostate cancer. Despite the methods' clinical potential, the liver is a particularly challenging organ for HIFU treatment due to the combined effect of respiratory-induced liver motion, partial blocking by the rib cage, and high perfusion/flow. Several technical and clinical solutions have been developed by various groups during the past 15 years to compensate for these problems. A review of current unmet clinical needs is given here, as well as a consensus from a panel of experts about technical and clinical requirements for upcoming pilot and pivotal studies in order to accelerate the development and adoption of focused ultrasound for the treatment of primary and secondary liver cancer.

Indexed as

Focused ultrasoundHigh-intensity ultrasoundLiver cancerNon-invasive surgeryUltrasound

Identifiers

PMID25512859
PMCPMC4265946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.